The dose-response graph of SDF-1 indicated that a concentration as low as 5 ng/mL rendered HAL-01 B-ALL cells completely resistant to Dex (Supplementary Fig. 20e). Here, CXCL12 is linked to acute lymphoblastic leukemia.